SIMFO

Bayreuth, Germany Founded: 2000 • Age: 26 yrs
Analytics platform for precision cancer diagnostics and therapy is developed.
Annual revenue - Latest available
Total funding - 2 rounds
Employees 12 Tracked headcount
Investors 1 Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About SIMFO

SIMFO is a company based in Bayreuth (Germany) founded in 2000. The company has 12 employees as of December 31, 2019. SIMFO offers products and services including maintrac®. SIMFO operates in a competitive market with competitors including NantHealth, Atrys, Evelo Biosciences, BioAge Labs and PathogenDX, among others.

  • Headquarter Bayreuth, Germany
  • Employees 12 as on 31 Dec, 2019
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Simfo Gmbh
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $311.23 K (USD), Grant

    Nov 01, 2019

  • Investors
  • Employee Count
    12

    as on Dec 31, 2019

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SIMFO

SIMFO offers a comprehensive portfolio of products and services, including maintrac®.

Product name locked
Category locked
Primary

Platform for detecting circulating tumor cells to monitor cancer therapy.

Funding Insights of SIMFO

Investors in SIMFO

SIMFO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for SIMFO

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SIMFO

Investments
Premium access

Investment portfolio details for SIMFO

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SIMFO

Premium access

Detailed financials for SIMFO

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Simfo Comparisons

SIMFO Primary company
Description
Analytics platform for precision cancer diagnostics and ther...
Location
Bayreuth, Germany
Founded Year
2000
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
12
As of 2019
Premium access

Peer comparison for SIMFO

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SIMFO

SIMFO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NantHealth, Atrys, Evelo Biosciences, BioAge Labs and PathogenDX, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Bioinformatics platforms are provided for cancer treatment identification.
Locked Locked Locked
Provider of diagnostic and therapeutic services catering to cancer
Locked Locked Locked
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
Locked Locked Locked
Bioinformatics platform is provided for biomarkers and drug discovery.
Locked Locked Locked
Provider of DNA-based pathogen testing kits
Locked Locked Locked
Molecular cancer profiling is conducted via genomics and proteomics.
Premium access

Detailed competitors of SIMFO

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Simfo

Premium access

Complete news archive for SIMFO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SIMFO

SIMFO was founded in 2000 and raised its 1st funding round 16 years after it was founded.

SIMFO is headquartered in Bayreuth, Germany. It is registered at Bayreuth, Bavaria, Germany.

Ulrich Pachmann is the current CEO of SIMFO.

As of Dec 31, 2019, the latest employee count at SIMFO is 12.

SIMFO was founded in 2000 in Bayreuth, Germany, within the biotechnology sector. Operations center on an analytics platform called maintrac, which supports early detection of circulating tumor cells. Identification of therapies is enabled through examination of scientific studies and preclinical drug development stages. Differentiation between treatment responders and non-responders is achieved via diagnostic analysis. The platform aids precision oncology efforts across research and clinical applications.

SIMFO's top competitors include NantHealth, BioAge Labs and PathogenDX.

SIMFO offers maintrac®.

SIMFO has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available